Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-07

Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating clascoterone cream 1% for acne in skin of color patients has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clascoterone cream 1% (clascoterone)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2025-05-07